Vaccine for tumor immunotherapy
US9790260B2 · kind B2 · utility
1Cited by
4References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 31, 2012 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Oct 31, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a vaccine comprising dendritic cells and bacterial ghosts for tumor immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.